165 related articles for article (PubMed ID: 15733028)
1. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
de Vries CS; Bromley SE; Thomas H; Farmer RD
Drug Saf; 2005; 28(3):241-9. PubMed ID: 15733028
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
3. Tibolone and risk of gynecological hormone sensitive cancer.
Løkkegaard ECL; Mørch LS
Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
[TBL] [Abstract][Full Text] [Related]
4. Tibolone: cancers of the breast and endometrium.
Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer patients and tibolone: a matched case-control study.
Lee KB; Lee JM; Lee JK; Cho CH
Maturitas; 2006 Oct; 55(3):264-9. PubMed ID: 16678984
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997.
Pukkala E; Tulenheimo-Silfvast A; Leminen A
Cancer Causes Control; 2001 Feb; 12(2):111-5. PubMed ID: 11246839
[TBL] [Abstract][Full Text] [Related]
7. [Modern tendencies in HRT of patients treated for endometrial cancer].
Ivanov C
Akush Ginekol (Sofiia); 2009; 48(2):20-2. PubMed ID: 20198772
[TBL] [Abstract][Full Text] [Related]
8. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
9. Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Wierik EJ; Hendricks PT; Boerstoel-Streefland M
Climacteric; 2004 Jun; 7(2):197-209. PubMed ID: 15497909
[TBL] [Abstract][Full Text] [Related]
10. Endometrial effects of tibolone.
Archer DF; Hendrix S; Gallagher JC; Rymer J; Skouby S; Ferenczy A; den Hollander W; Stathopoulos V; Helmond FA
J Clin Endocrinol Metab; 2007 Mar; 92(3):911-8. PubMed ID: 17192288
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy use and the risk of stroke.
Renoux C; Dell'aniello S; Garbe E; Suissa S
Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
[TBL] [Abstract][Full Text] [Related]
14. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
Plumb JM; Guest JF
Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401
[TBL] [Abstract][Full Text] [Related]
15. Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women.
Velthuis-Te Wierik EJ; Hendricks PT; Martinez C
Menopause; 2007; 14(3 Pt 1):518-27. PubMed ID: 17224856
[TBL] [Abstract][Full Text] [Related]
16. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
[TBL] [Abstract][Full Text] [Related]
17. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
18. The influence of hormone therapies on type I and II endometrial cancer: A nationwide cohort study.
Mørch LS; Kjaer SK; Keiding N; Løkkegaard E; Lidegaard Ø
Int J Cancer; 2016 Mar; 138(6):1506-15. PubMed ID: 26421912
[TBL] [Abstract][Full Text] [Related]
19. Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen.
Kurtay G; Berker B; Demirel C
J Reprod Med; 2004 Nov; 49(11):893-8. PubMed ID: 15603100
[TBL] [Abstract][Full Text] [Related]
20. Attitudes and practices of Korean gynecologists towards hormone replacement therapy in endometrial cancer survivors.
Lee SJ; Yeo SG; Kang SB; Park DC
Eur J Gynaecol Oncol; 2013; 34(6):513-7. PubMed ID: 24601041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
